Professor Bruce Morland
Professor of Paediatric Oncology
Professor Morland manages children with non-CNS (Central Nervous System) solid tumours. He is an international expert in the treatment of liver and bone tumours. He has extensive experience in the development of novel new therapies for childhood cancer and the conduct of early phase clinical trials. Dr Morland has been involved in the organisation of national cancer services for children for many years and has previously been Chairman of the Children’s Cancer and Leukaemia Group.
Professor Morland is one of the Deputy Chief Medical Officers at the Hospital and Associate Medical Director at the Royal Orthopaedic Hospital (ROH). He is involved in strategic planning of the hospital’s services and in particular the move of the specialist paediatric Bone Cancer surgical service to the Children’s Hospital from ROH.
Professor Morland’s own research interests are in drug discovery and early phase clinical trials and he is founder and board member of the Innovative Therapies for Childhood Cancer (ITCC) European network. He has led the International Liver Cancer Group (SIOPEL) and is the European lead for the PHITT trial for children with liver cancer working in collaboration with centres throughout Europe, USA and Japan.
0121 333 8233
- Liver and bone tumours
- Research - drug discovery
- Early phase clinical trials